Proton pump inhibitor and histamine‐2 receptor antagonist use and risk of liver cancer in two population‐based studies

Abstract

We found some evidence that PPI use was associated with liver cancer. Whether this association is causal or reflects residual confounding or reverse causation requires additional research.